At a Glance
| N-Methylbisfluoromodafinil | Adrafinil | |
|---|---|---|
| Class | Stimulants, Nootropic, Eugeroics | Stimulants, Nootropic, Eugeroics |
| Common Dose (oral) | 100–150 mg | 250–400 mg |
| Total Duration | — | 6.3–9 hrs |
| Routes | oral | oral |
N-Methylbisfluoromodafinil, a Stimulants, Nootropic, Eugeroics, and Adrafinil, a Stimulants, Nootropic, Eugeroics, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Stimulants, Nootropic, Eugeroicss, meaning they share a common pharmacological foundation. They share 8 documented effects in common, with 11 effects unique to N-Methylbisfluoromodafinil and 1 unique to Adrafinil. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| N-Methylbisfluoromodafinil | Adrafinil | |
|---|---|---|
| Class | Stimulants, Nootropic, Eugeroics | Stimulants, Nootropic, Eugeroics |
| Common Dose (oral) | 100–150 mg | 250–400 mg |
| Total Duration | — | 6.3–9 hrs |
| Routes | oral | oral |
| Effects | 19 documented | 9 documented |
| Interaction | Caution | |
| Level | N-Methylbisfluoromodafinil | Adrafinil |
|---|---|---|
| Threshold | 25 mg | 100 mg |
| Light | 50–100 mg | 150–250 mg |
| Common | 100–150 mg | 250–400 mg |
| Strong | 150–200 mg | 400–600 mg |
| Heavy | 200 mg | 600 mg |
N-Methylbisfluoromodafinil
Adrafinil
Increased cardiovascular strain and neurotoxicity risk